Outset Medical Inc. (OM) News

Outset Medical Inc. (OM): $21.24

0.66 (+3.21%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter OM News Items

OM News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

OM News Highlights

  • For OM, its 30 day story count is now at 14.
  • Over the past 20 days, the trend for OM's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
  • ROSE, AREN and BEAT are the most mentioned tickers in articles about OM.

Latest OM News From Around the Web

Below are the latest news stories about Outset Medical Inc that investors may wish to consider to help them evaluate OM as an investment opportunity.

Outset Medical to Present at 42nd Annual Cowen Health Care Conference

SAN JOSE, Calif., February 22, 2022--Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 42nd Annual Cowen Health Care Conference on Tuesday, March 8, 2022 at 11:50am PT / 2:50pm ET.

Yahoo | February 22, 2022

Outset Medical stock soars 14% as Q4 revenue rises 63% Y/Y

Outset Medical (OM +14.1%) rose Feb. 17, after Q4 revenues grew ~63.2% Y/Y to $28.15M. The company also said that Leslie Trigg was appointed Chair of the board in addition to her ongoing role as president and CEO. Former Chairman D. Keith Grossman will continue to serve on the board and has...

Seeking Alpha | February 17, 2022

Outset Medical More Than Doubles Sales In FY21, Issues Better Than Expected FY22 Outlook

Outset Medical Inc (NASDAQ: OM ) recorded Q4 FY21 net revenue of $28.2 million , a 63.2%, beating the consensus of $26.42 million. Product revenue for the fourth quarter of 2021 was $23.7 million, +79.5%. The Company achieved a gross margin of 11.8%, compared to 2.4% in the fourth quarter of 2020 Select … Full story available on Benzinga.com

Benzinga | February 17, 2022

As Markets Fall, These 2 Nasdaq Stocks Are Surging Higher

After a terrible January, investors had hoped that stock markets would be able to recover in February. As of 2:45 p.m. ET, the Nasdaq was down almost 2.5% Thursday afternoon. Today, some of the best performers include Nasdaq stocks Outset Medical (NASDAQ: OM) and Global-e Online (NASDAQ: GLBE).

Yahoo | February 17, 2022

Outset Medical, Inc. (OM) Leslie Trigg on Q4 2021 Earnings Call Transcript

No summary available.

Seeking Alpha | February 16, 2022

Outset Medical Reports Fourth Quarter and Full Year 2021 Financial Results

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2021. The Company also announced that Leslie Trigg has been appointed Chair of the Board of Directors in addition to her ongoing role as President and Chief Executive Officer. Recent Highlights

Business Wire | February 16, 2022

Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates

Outset Medical, Inc. (OM) delivered earnings and revenue surprises of -14.93% and 6.04%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 16, 2022

Outset Medical Q4 2021 Earnings Preview (NASDAQ:OM)

Outset Medical (NASDAQ:OM) is scheduled to announce Q4 earnings results on Wednesday, February 16th, after market close.The consensus EPS Estimate is -$0.67 (-11.7% Y/Y) and the…

Seeking Alpha | February 15, 2022

The Arena Group Announces Pricing of $30,000,000 Public Offering, Following February 9, 2022 Uplisting to the NYSE American

NEW YORK, February 11, 2022--The Arena Group Holdings, Inc., formerly known as theMaven, Inc. (NYSEAMERICAN: AREN) (the "Company"), today announced the pricing of an underwritten public offering of 3,636,364 shares of its common stock at a public offering price of $8.25 per share. The gross proceeds to the Company from this offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately $30,000,000. The offering is expected to c

Yahoo | February 11, 2022

Earnings Preview: Outset Medical, Inc. (OM) Q4 Earnings Expected to Decline

Outset Medical, Inc. (OM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 9, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8624 seconds.